Med. praxi. 2010;7(3):105-110

Diuretics in hypertension

doc.MUDr.Jiří ©pác, CSc., prof.MUDr.Miroslav Souček, CSc., MUDr.Bohuslav Kianička
II. interní klinika FN u sv. Anny v Brně

Diuretics are one of the longest used drug class in hypertension treatment. In clinical practice they have been used since 1957 and their

discovery is due to research in the field of antibacterial sulfonamides conducted during the 1950s in Merck Sharp and Dohme laboratories.

Keywords: diuretics, hypertension

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©pác J, Souček M, Kianička B. Diuretics in hypertension. Med. praxi. 2010;7(3):105-110.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hughes AD. How do thiazide and thiazide-like diuretics lower blood pressure? Journal of the Renin-Angiotensin-Aldosterone System, 2004; 5(4): 155-160. Go to original source... Go to PubMed...
    2. Chapman AB, Schwartz GL, Boerwinkle E, Turner ST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int. 2002; 61: 1047-1055. Go to original source... Go to PubMed...
    3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265: 3255-3264. Go to original source...
    4. Sica DA. Chlorthalidone: Has It Always Been the Best Thiazide-Type Diuretic? Hypertension. 2006; 47: 321-322. Go to original source... Go to PubMed...
    5. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Phillips BB, Zimmerman MB, Bergus GR. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006; 47: 352-358. Go to original source... Go to PubMed...
    6. Chen JMH, Heran BS, Wright JM, et al. Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension. Cochrane Database Syst Rev 2009. Go to original source... Go to PubMed...
    7. Yip GWK, Wang M, Chan S, Fung JWH, et al. Heart failure and cardiomyopathy: The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 2008; 94: 573-580. Go to original source... Go to PubMed...
    8. Bakris G, Molitch M, Hewkin A, Kipnes M, Sarafidis P, et al. Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome. Diabetes Care 2006; 29: 2592-2597. Go to original source... Go to PubMed...
    9. Schini VB, De Mey J, Vanhoutte PM. Effect of indapamide on endothelium-dependent relaxations in isolated canine femoral arteries. Am J Cardiol 1990; 65: 7H-10H. Go to original source... Go to PubMed...
    10. ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 829-840. Go to original source... Go to PubMed...
    11. Wolf RL, Mendlowitz M, Roboz J, Styan GP, Kornfeld P, Weigl A. Treatment of hypertension with spironolactone. JAMA. 1966; 198: 1143-1149. Go to original source... Go to PubMed...
    12. Williams GH, Burgess E, Kolloch RE, et al. Efficacy of eplerenon vs enalapril as monotherapy in systemic hypertension. Am. J. Cardiol, 2004; 93: 990-996. Go to original source... Go to PubMed...
    13. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, et al. Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy: The 4E-Left Ventricular Hypertrophy Study. Circulation. 2003; 108: 1831-1838. Go to original source... Go to PubMed...
    14. Chapman N, Dobson J, Wilson S, Dahlöf B, Sever PS, Wedel H, Poulter NR. Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension. Hypertension. 2007; 49: 1-7. Go to original source... Go to PubMed...
    15. Papademetriou V, Burris JF, et al. Thiazide Therapy Is Not a Cause of Arrhythmia in Patients With Systemic Hypertension. Arch Intern Med. 1988; 148(6): 1272-1276. Go to original source...
    16. Franse LV, Pahor M, DiBari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in SHEP. Hypertension. 2000; 35: 1025-1030. Go to original source... Go to PubMed...
    17. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288: 2981-2997.
    18. Nikas S, Rizos E, Milionis H, Bairaktari E, Kalaitzidis R, et al. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide. J Renin Angiotensin Aldosterone Syst 2000; 1: 289-291. Go to original source... Go to PubMed...
    19. Carter BL, Einhorn PT, Brands M, He J, Cutler JA, Whelton PK, Bakris GL, Brancati FL, Cushman WC, Oparil S, Wright JT Jr. Thiazie-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. Hypertension. 2008; 52: 30-36. Go to original source... Go to PubMed...
    20. Lindholm LH, Persson M, Alanpovic P, Carlberg BO, Svensson A, Samuelsson O. Metabolic outcome during 1 year in newly detected hypertensive: Results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE). J Hypertens 2003; 21: 1563-1574. Go to original source...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.